First 3D printed drug approved by US FDA now on the market
An epilepsy medication developed by Aprecia Pharmaceuticals, SPRITAM®, the first 3D printed drug approved by the US FDA, is now available on the market.
Please sign in or register for FREE
Sign in to 3DMedNet
Register to 3DMedNet – 3D Printing in Medicine Network
3DMedNet is a free content and networking hub aiming to encourage knowledge-sharing, interaction and discussion within the diverse 3D printing in medicine and healthcare community.